Étiquette : USA

Adolescent Treatment Admissions for Marijuana Following Recreational Legalization in Colorado and Washington, Jeremy Mennis, Gerald J Stahler, 2020

Adolescent Treatment Admissions for Marijuana Following Recreational Legalization in Colorado and Washington Jeremy Mennis, Gerald J Stahler Drug and Alcohol Dependence, 2020 May 1, 210, 107960. doi : 10.1016/j.drugalcdep.2020.107960 Abstract Introduction : There is concern that recreational marijuana legalization (RML) may lead to increased cannabis use disorder (CUD) among youth due to increased marijuana use. This study investigates whether adolescent substance use disorder treatment admissions for marijuana use increased in Colorado and Washington following RML. Methods : Annual data on 2008-2017 treatment admissions for marijuana use from the SAMHSA TEDS-A dataset for adolescents age 12-17 were used to model state treatment admissions trends. [...]

Lire la suite

Cannabis Misconceptions Still Common Among MS Clinicians, Nancy Melville, Medscape.com, 2020

Cannabis Misconceptions Still Common Among MS Clinicians Nancy Melville June 05, 2020 https://www.medscape.com/viewarticle/931872?nlid=135873_425&src=WNL_mdplsfeat_200609_mscpedit_psyc&uac=292598PZ&spon=12&impID=2413707&faf=1   Despite the ever-increasing acceptance of medical cannabis and its notably common use in patients with multiple sclerosis (MS), clinicians treating those patients still may be poorly informed about risks, benefits, regulations, and proper uses, experts say. "There is evidence of a 'clinical void,' with clinicians on one side and people with MS and other conditions on the other that doesn't usually exist regarding therapies that people with MS are using," said Allen C. Bowling, MD, PhD, director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado, in Aurora. His [...]

Lire la suite

Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado, Amalie K. Kropp Lopez et al., 2020

Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado Amalie K. Kropp Lopez, Stephanie D. Nichols, Daniel Y. Chung, Daniel E. Kaufman, Kenneth L. McCall  and Brian J. Piper International Journal of Environmental Research and Public Health, 2020, 17, 3251 doi : 10.3390/ijerph17093251   Abstract : There have been dynamic changes in prescription opioid use in the US but the state level policy factors contributing to these are incompletely understood. We examined the association between the legalization of recreational marijuana and prescription opioid distribution in Colorado. Utah and Maryland, two states that had not legalized recreational marijuana, were selected for comparison. Prescription data reported to [...]

Lire la suite

5 Ways Quarantine Has Changed the Cannabis Industry Forever, T.L. Stanley, May 5, 2020

5 Ways Quarantine Has Changed the Cannabis Industry Forever Covid-19 lockdown sparks a 'green rush,' changing how consumers shop By T.L. Stanley | May 5, 2020 https://www.adweek.com/digital/5-ways-quarantine-has-changed-the-cannabis-industry-forever/ As cannabis brands emerge from months in quarantine, how will they be changed by the experience? Key insights: New shopping methods aren't just a crisis response. They're also super convenient. Move over, brownies. Demand for next-gen edibles and infused products is skyrocketing. Budget tightening? Meet the new value brands of cannabis. Stuck in quarantine for weeks on end and hoarding necessities, consumers have made their Covid-19 buying preferences extremely clear: toilet paper, frozen pizza, jigsaw puzzles and hand sanitizer. For certain consumers, [...]

Lire la suite

Etats-Unis : l’Epidiolex n’est plus une substance contrôlée, Aurélien BERNARD, 2020

Etats-Unis : l’Epidiolex n’est plus une substance contrôlée Aurélien BERNARD Newsweed.fr, 8 avril 2020   https://www.newsweed.fr/etats-unis-lepidiolex-nest-plus-une-substance-controlee/     GW Pharmaceuticals a annoncé lundi que l’Epidiolex, un médicament à base de cannabidiol (CBD) utilisé dans le traitement de l’épilepsie, avait été retiré de l’annexe V de la Loi américaine sur les substances contrôlées par la Drug Enforcement Administration (DEA). Les personnes qui pourraient en bénéficier pourront dorénavant en obtenir plus facilement. GW a déclaré dans son communiqué qu’il « entamera maintenant le processus de mise en œuvre de ces changements au niveau de l’État et via le réseau de distribution EPIDIOLEX ». Comme pour de nombreux médicaments non-contrôlés, les malades ou leurs [...]

Lire la suite

The Consciousness Research of Stanislav Grof, Richard Yensen & Donna Dryer, 1998

The Consciousness Research of Stanislav Grof : A Cosmic Portal Beyond Individuality By Richard Yensen, Ph.D. and Donna A. Dryer, M.D., M.P.H. ©1998 Richard Yensen & Donna Dryer     I. Introduction Stanislav Grof began his research in Prague, Czechoslovakia, as a psychiatric resident, in the late 1950’s. His initial observations seemed to confirm and offer a laboratory proof for many of the basic tenets of Freudian psychoanalytic thought. At that time his conclusion was politically unsettling because psychoanalysis was repressed in the iron curtain countries. Forty years later the outcome of Grof’s continued research is a theoretical framework for understanding human consciousness. His theory has [...]

Lire la suite

San Fran­cisco et New York classent la vente de weed comme « service essen­tiel » durant l’épi­dé­mie, PrincipesActifs.org, mars 2020

San Fran­cisco et New York classent la vente de weed comme « service essen­tiel » durant l’épi­dé­mie Accueil » A l'international » PrincipesActifs.org, Publié le 21 Mars 2020 https://www.principesactifs.org/san-francisco-et-new-york-classent-la-vente-de-weed-comme-service-essentiel-durant-lepidemie/   Alors que les commerces ferment les uns après les autres aux États-Unis pour endi­guer la pandé­mie de coro­na­vi­rus (Covid-19), certains États et certaines Villes améri­caines ont classé les boutiques de canna­bis parmi les « services essen­tiels ». Elles pour­ront donc rester ouvertes malgré les mesures de confi­ne­ment, rappor­tait la radio publique NPR mercredi 18 mars. La Ville de San Fran­cisco exige que ses habi­tants restent chez eux, à moins qu’ils four­nissent un « service essen­tiel [...]

Lire la suite

Where Is Marijuana Legal in the US? [2020], Testclear.com, 2020

Where Is Marijuana Legal in the US? [2020] https://www.testclear.com/Where-Is-Marijuana-Legal-in-the-US-2020.aspx     Marijuana continues to tread between legal and illegal status, depending on where you are looking in the US and for what purpose you are using the substance. Where Is Marijuana Legal?   Medical Marijuana   Recreational Marijuana   Decriminalized   THC-low, CBD-High Allowed Table of Contents Where Is Marijuana Legal? Where Is Marijuana Decriminalized? What Are State Marijuana Laws? What Is the Impact of Marijuana Legalization? What Is the Cole Memorandum? Is Marijuana Legal at the Federal Level? What’s Next for the Legalization of Marijuana? Where Does the Public Stand on Marijuana? What Can You Do? As far as the [...]

Lire la suite

The current state and future perspectives of cannabinoids in cancer biology, Paweł Śledziński et al., 2018

The current state and future perspectives of cannabinoids in cancer biology Paweł Śledziński, Joanna Zeyland, Ryszard Słomski & Agnieszka Nowak Cancer Medicine, 2018, 7, (3), 765–775. doi : 10.1002/cam4.1312   Abstract To date, cannabinoids have been allowed in the palliative medicine due to their analgesic and antiemetic effects, but increasing number of preclinical studies indicates their anticancer properties. Cannabinoids exhibit their action by a modulation of the signaling pathways crucial in the control of cell proliferation and survival. Many in vitro and in vivo experiments have shown that cannabinoids inhibit proliferation of cancer cells, stimulate autophagy and apoptosis, and have also a potential to inhibit angiogenesis [...]

Lire la suite

Stroke in young cannabis users (18-49 years) : National trends in hospitalizations and outcomes, Rupak Desai et al., 2019

Stroke in young cannabis users (18-49 years) : National trends in hospitalizations and outcomes Rupak Desai, Sandeep Singh, Krupa Patel, Hemant Goyal, Manan Shah, Zeeshan Mansuri, Smit Patel, Zabeen K Mahuwala, Larry B Goldstein and Adnan I Qureshi International Journal of Stroke, 2019, doi: 10.1177/1747493019895651 Abstract BACKGROUND : Recent legalization of therapeutic and recreational cannabis use makes it imperative to have an insight into odds and trends in young-onset stroke-related hospitalizations among cannabis users (18-49 years). METHODS : The National Inpatient Sample dataset (2007-2014) was utilized to assess national trends, odds of young-onset stroke-related hospitalizations, and outcomes among cannabis users vs. nonusers using provided discharge weights, [...]

Lire la suite